Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Antiretroviral Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Antiretroviral Drugmarket, defines the market attractiveness level of Antiretroviral Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Antiretroviral Drug industry, describes the types of Antiretroviral Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Antiretroviral Drug market and the development prospects and opportunities of Antiretroviral Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Antiretroviral Drug market in Chapter 13.
By Player:
AbbVie
CIPLA
Bristol-Myer Squibb
Merck
Boehringer-Ingelheim
Johnson and Johnson
ViiV Healthcare
Gilead Sciences
By Type:
Multi-Class Drugs Combination
Non Nucleoside Reverse Transcriptase Inhibitors
Protease Inhibitors
Other
By End-User:
Hospital
Pharmaceutical Companies
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Antiretroviral Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Antiretroviral Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Antiretroviral Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Antiretroviral Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Antiretroviral Drug Market Analysis and Outlook to 2022
-
7.1 Global Antiretroviral Drug Consumption (2017-2022)
-
7.2 United States Antiretroviral Drug Consumption (2017-2022)
-
7.3 Europe Antiretroviral Drug Consumption (2017-2022)
-
7.4 China Antiretroviral Drug Consumption (2017-2022)
-
7.5 Japan Antiretroviral Drug Consumption (2017-2022)
-
7.6 India Antiretroviral Drug Consumption (2017-2022)
-
7.7 South Korea Antiretroviral Drug Consumption (2017-2022)
8 Region and Country-wise Antiretroviral Drug Market Analysis and Outlook to 2028
-
8.1 Global Antiretroviral Drug Consumption Forecast (2022-2028)
-
8.2 United States Antiretroviral Drug Consumption Forecast (2022-2028)
-
8.3 Europe Antiretroviral Drug Consumption Forecast (2022-2028)
-
8.4 China Antiretroviral Drug Consumption Forecast (2022-2028)
-
8.5 Japan Antiretroviral Drug Consumption Forecast (2022-2028)
-
8.6 India Antiretroviral Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Antiretroviral Drug Consumption Forecast (2022-2028)
9 Global Antiretroviral Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Antiretroviral Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Multi-Class Drugs Combination Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Non Nucleoside Reverse Transcriptase Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Protease Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Antiretroviral Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Pharmaceutical Companies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Antiretroviral Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Antiretroviral Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Multi-Class Drugs Combination Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Non Nucleoside Reverse Transcriptase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Protease Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Antiretroviral Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Pharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Antiretroviral Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Antiretroviral Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Antiretroviral Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Antiretroviral Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Antiretroviral Drug Market Competitive Analysis
-
14.1 AbbVie
-
14.1.1 AbbVie Company Details
-
14.1.2 AbbVie Antiretroviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 AbbVie Antiretroviral Drug Product and Service
-
14.2 CIPLA
-
14.2.1 CIPLA Company Details
-
14.2.2 CIPLA Antiretroviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 CIPLA Antiretroviral Drug Product and Service
-
14.3 Bristol-Myer Squibb
-
14.3.1 Bristol-Myer Squibb Company Details
-
14.3.2 Bristol-Myer Squibb Antiretroviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bristol-Myer Squibb Antiretroviral Drug Product and Service
-
14.4 Merck
-
14.4.1 Merck Company Details
-
14.4.2 Merck Antiretroviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Merck Antiretroviral Drug Product and Service
-
14.5 Boehringer-Ingelheim
-
14.5.1 Boehringer-Ingelheim Company Details
-
14.5.2 Boehringer-Ingelheim Antiretroviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Boehringer-Ingelheim Antiretroviral Drug Product and Service
-
14.6 Johnson and Johnson
-
14.6.1 Johnson and Johnson Company Details
-
14.6.2 Johnson and Johnson Antiretroviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Johnson and Johnson Antiretroviral Drug Product and Service
-
14.7 ViiV Healthcare
-
14.7.1 ViiV Healthcare Company Details
-
14.7.2 ViiV Healthcare Antiretroviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 ViiV Healthcare Antiretroviral Drug Product and Service
-
14.8 Gilead Sciences
-
14.8.1 Gilead Sciences Company Details
-
14.8.2 Gilead Sciences Antiretroviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Gilead Sciences Antiretroviral Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Antiretroviral Drug
-
Figure Antiretroviral Drug Picture
-
Table Global Antiretroviral Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Antiretroviral Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Antiretroviral Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Antiretroviral Drug Consumption by Country (2017-2022)
-
Figure United States Antiretroviral Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Antiretroviral Drug Consumption and Growth Rate (2017-2022)
-
Figure China Antiretroviral Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Antiretroviral Drug Consumption and Growth Rate (2017-2022)
-
Figure India Antiretroviral Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Antiretroviral Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Antiretroviral Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Antiretroviral Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Antiretroviral Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Antiretroviral Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Antiretroviral Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Antiretroviral Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Antiretroviral Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Multi-Class Drugs Combination Consumption and Growth Rate (2017-2022)
-
Figure Global Non Nucleoside Reverse Transcriptase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Protease Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmaceutical Companies Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Multi-Class Drugs Combination Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non Nucleoside Reverse Transcriptase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Protease Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmaceutical Companies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Antiretroviral Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Antiretroviral Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Antiretroviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Antiretroviral Drug Product and Service
-
Table CIPLA (Foundation Year, Company Profile and etc.)
-
Table CIPLA Antiretroviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table CIPLA Antiretroviral Drug Product and Service
-
Table Bristol-Myer Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myer Squibb Antiretroviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myer Squibb Antiretroviral Drug Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Antiretroviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Antiretroviral Drug Product and Service
-
Table Boehringer-Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer-Ingelheim Antiretroviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer-Ingelheim Antiretroviral Drug Product and Service
-
Table Johnson and Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson and Johnson Antiretroviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson and Johnson Antiretroviral Drug Product and Service
-
Table ViiV Healthcare (Foundation Year, Company Profile and etc.)
-
Table ViiV Healthcare Antiretroviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table ViiV Healthcare Antiretroviral Drug Product and Service
-
Table Gilead Sciences (Foundation Year, Company Profile and etc.)
-
Table Gilead Sciences Antiretroviral Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Sciences Antiretroviral Drug Product and Service
-
